Aurinia Historical Cash Flow
| AUPH Stock | USD 8.98 0.03 0.34% |
Analysis of Aurinia Pharmaceuticals cash flow over time is an excellent tool to project Aurinia Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 4.7 M or Depreciation of 12.2 M as it is a great indicator of Aurinia Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Aurinia Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aurinia Pharmaceuticals is a good buy for the upcoming year.
Aurinia |
About Aurinia Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Aurinia balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Aurinia's non-liquid assets can be easily converted into cash.
Aurinia Pharmaceuticals Cash Flow Chart
Add Fundamental
Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Aurinia Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Aurinia Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Investments
Securities or assets acquired for generating income or appreciating in value, not used in daily operations.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Aurinia Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Aurinia Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurinia Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Aurinia Stock please use our How to Invest in Aurinia Pharmaceuticals guide.As of now, Aurinia Pharmaceuticals' Sale Purchase Of Stock is increasing as compared to previous years. The Aurinia Pharmaceuticals' current Change To Netincome is estimated to increase to about 39.6 M, while Change In Cash is forecasted to increase to (43 M).
Aurinia Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Aurinia Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aurinia Pharmaceuticals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 188.1M | (33.7M) | (40.5M) | (137.7M) | (45.3M) | (43.0M) | |
| Free Cash Flow | (63.6M) | (77.2M) | (159.2M) | (79.8M) | (34.2M) | (35.9M) | |
| Change In Working Capital | 2.1M | 4.5M | (21.6M) | (6.8M) | (5.6M) | (5.3M) | |
| Begin Period Cash Flow | 118.0M | 306.0M | 272.4M | 231.9M | 94.2M | 62.0M | |
| Other Cashflows From Financing Activities | 20.7M | 6.6M | 24.4M | 2.4M | 4.9M | 4.7M | |
| Depreciation | 1.5M | 1.4M | 2.8M | 2.7M | 11.6M | 12.2M | |
| Other Non Cash Items | 8.2M | 9.5M | 10.9M | 462K | (6.8M) | (6.5M) | |
| Capital Expenditures | 104K | 7.3M | 1.5M | 292K | 718K | 1.0M | |
| Total Cash From Operating Activities | (63.5M) | (69.9M) | (157.7M) | (79.5M) | (33.5M) | (35.1M) | |
| Net Income | (123.8M) | (102.7M) | (181.0M) | (108.2M) | (78.0M) | (74.1M) | |
| Total Cash From Financing Activities | 243.7M | 194.4M | 221.1M | 2.4M | (5.1M) | (4.9M) | |
| End Period Cash Flow | 306.0M | 272.4M | 231.9M | 94.2M | 48.9M | 63.8M | |
| Sale Purchase Of Stock | 4.0M | 243.9M | 194.4M | 221.1M | 254.3M | 267.0M | |
| Investments | 7.8M | (150.8M) | (84.5M) | (60.6M) | (3.5M) | (3.6M) | |
| Total Cashflows From Investing Activities | 7.8M | (158.2M) | (103.9M) | (60.6M) | (54.6M) | (51.8M) | |
| Change To Account Receivables | (151K) | (13.6M) | (15.4M) | 1.9M | (10.6M) | (10.1M) | |
| Change To Operating Activities | (2.0M) | 4.8M | (4.7M) | (3.4M) | (3.1M) | (2.9M) | |
| Change To Netincome | 21.6M | 20.1M | 42.1M | 32.8M | 37.7M | 39.6M | |
| Change To Liabilities | 4.0M | 13.6M | 4.1M | 3.7M | 4.3M | 4.5M | |
| Stock Based Compensation | 7.4M | 17.5M | 31.2M | 32.3M | 45.3M | 47.6M |
Currently Active Assets on Macroaxis
When determining whether Aurinia Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurinia Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurinia Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurinia Pharmaceuticals Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurinia Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Aurinia Stock please use our How to Invest in Aurinia Pharmaceuticals guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurinia Pharmaceuticals. If investors know Aurinia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aurinia Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 1.536 | Quarterly Revenue Growth 0.243 | Return On Assets (0.02) | Return On Equity (0.06) |
The market value of Aurinia Pharmaceuticals is measured differently than its book value, which is the value of Aurinia that is recorded on the company's balance sheet. Investors also form their own opinion of Aurinia Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aurinia Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aurinia Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aurinia Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aurinia Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurinia Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurinia Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.